Evotec collaborates with Leukemia & Lymphoma Society
Wednesday, November 6, 2013
Evotec partners with LLS to support selected programs and principal investigators with resources for high-throughput screening and optimization of small molecules into drug-like compounds. Evotec delivers an industrialized, comprehensive and unbiased drug discovery infrastructure to support innovation efficiency as part of a fully integrated solution.
Financial details were not disclosed.